ImYoo
Patient-driven biodiscovery platform advancing immune biology with patients at the center
health AI / medtech / digital health
Stageseed
Founded2021
Employees8
LocationMountain View, CA
Business modelB2B2C / platform
About
ImYoo is debugging the human immune system. By coupling at-home blood collection and single-cell RNA sequencing, we enable high resolution insights across time.
Product
- Value proposition
- A discovery platform that enables patient-driven, at-home sample collection and multi-omic immune profiling to inform precision diagnosis and therapies, starting with Lupus.
- Target customers
- researchers, clinicians, and patient communities focusing on autoimmune diseases, starting with Lupus
Founders
- Tatyana Dobreva — CEO and Co-founder
- David Brown — CTO and Co-founder
Categories
biotechbiomedical data platformgenomicsimmunologypatient-centered researchsoftware platform
Products
patient-enabled biodiscovery platformself-collection blood kitssingle-cell genomics assays platformmulti-omic immune profiling toolsdata & insights platform
Key features
patient-centric immune discovery studiesat-home self-collection of blood sampleshigh-resolution single-cell genomicsmulti-omics data integrationprecision diagnosis & therapy guidanceplatform for researchers and patients to collaborate
Technologies
single-cell genomicsmulti-omicsimmune profilingbiomarker discoverydata platformhome-based sample collection
Integrations
databaseplatformlab workflows (assumed)
Target conditions
Lupusimmune disordersautoimmune diseases
Care settings
homelabresearch facility
Traction metrics
patient-driven studiesat-home self-collection capability
Competitors
GenuVisAdaptive BiotechnologiesSOPHiA GENETICSTempusinsitro
Investors
Corundum Systems BiologyPsyMed VenturesFreeflow VenturesArben VenturesAdam DraperJared Hecht
News
- ImYoo Launches Patient-enabled Lupus Study to Track Steroid Tapering Outside the Clinic · 2026-01-09T21:08:07.000Z
- Bioinformatics @ GT x ImYoo Industry Talk | Campus Calendar · 2026-02-03T00:00:00.000Z
- Merck Digital Sciences Studio: Meet Our Third Cohort - NJII · 2024-12-02T19:26:40.000Z
- Bioinformatics @ GT x ImYoo Industry Talk | Campus Calendar · 2026-02-03T00:00:00.000Z
- Merck Digital Sciences Studio Showcases Third Cohort of Biotech Innovators in NYC - NJII · 2025-06-19T18:47:35.000Z
- ImYoo Launches Patient-enabled Lupus Study to Track Steroid Tapering Outside the Clinic · 2026-01-25T08:00:00.000Z
Browse similar startups
Related startups
- InfiGen AI — San Francisco, CA
- InflammaSense — San Diego, CA
- Intent.Health — Sacramento, CA
- IO Health — Pasadena, CA
- IQgenomyx — Sacramento, CA
- Joon Health (YC W22) — Oakland, CA
- Liberate Bio — Boston, MA
- Metanoia Bio Inc. — los angeles, CA
- nChroma Bio — Boston, MA
- Nine Diagnostics — Cambridge, MA
- Oral Genome — Carlsbad, CA
- Phinomics — San Carlos, CA
Profile updated Jul 29, 2026. Sources: imyoo.health
